Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia? [10]

Leukemia

Volumn 20, Issue 12, 2006, Pages 2193-2195

  Subramaniyam, S ^a   Nandula, S V ^a   Nichols, G ^a   Weiner, M ^a   Satwani, P ^a   Alobeid, B ^a   Bhagat, G ^a   Murty, V V ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; DAUNORUBICIN; IDARUBICIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; STEROID;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; BLOOD ANALYSIS; BONE MARROW BIOPSY; CANCER RESISTANCE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DELETION; GENE IDENTIFICATION; GENE MAPPING; GENE PROBE; GENETIC CODE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; KARYOTYPING; LETTER; LEUKEMIA REMISSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETINOIC ACID SYNDROME; RETREATMENT;

EID: 33751241752     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404406     Document Type: Letter

References (8)

1. Kakizuka A, Miller Jr WH, Umesono K, Warrell Jr RP, Frankel SR, Murty VV et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663-674.
2. Redner RL. Variations on a theme: The alternate translocations in APL. Leukemia 2002; 16: 1927-1932.
3. Mistry AR, Pedersen EW, Solomon E, Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia: Implications for the clinical management of the disease. Blood Rev 2003; 17: 71-97.
4. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581-3588.
5. Huntly BJ, Bench A, Green AR. Double jeopardy from a single translocation: Deletions of the derivative chromosome 9 in chronic myeloid leukemia. Blood 2003; 102: 1160-1168.
6. Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P et al. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 1995; 86: 1540-1547.
7. Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A et al. Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 2004; 103: 2358-2362.
8. Gu BW, Xiong H, Zhou Y, Chen B, Wang L, Dong S et al. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: Use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy. Proc Natl Acad Sci USA 2002; 99: 7640-7645.